Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial

被引：0

作者：

Shaukat Ali

Shobha Luxmi

Fatima Anjum

Sheikh Muhammad Muhaymin

Syed Muneeb Uddin

Ayesha Ali

Mir Rashid Ali

Sohaib Tauheed

Mujtaba Khan

Mohsin Bajwa

Saif Ullah Baig

Elisha Shalim

Iqra Ahmed

Abdul Samad Khan

Saeed Quraishy

机构：

[1] Dow University of Health Sciences,Dow College of Biotechnology

[2] Dow University Hospital,Dow International Medical College

[3] Dow University of Health Sciences,undefined

[4] Dow Research Institute of Biotechnology and Biomedical Sciences,undefined

[5] Dow University of Health Sciences,undefined

[6] Dow University of Health Sciences,undefined

[7] National Control Laboratory for Biologicals,undefined

[8] Dow University of Health Sciences,undefined

来源：

Trials | / 21卷

关键词：

COVID-19; Randomised controlled trial; protocol; passive immunization; anti-COVID19 IVIG; single dose; C-IVIG; convalescent plasma;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用